V025-0673 Screening compound: N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

V025-0673 Screening compound: N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide
V025-0673 Screening compound: N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-0673
N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-0673

Molecular Formula

C26H34N6O (C26 H34 N6 O)

Compound Name

N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

IUPAC name

N-(4-{[6-ethyl-3-methyl-1-(4-methylphenyl)-1H-pyrazolo[34-d]pyrimidin-4-yl]amino}cyclohexyl)cyclobutanecarboxamide

SMILES

CCc1nc(n(-c2ccc(C)cc2)nc2C)c2c(NC(CC2)CCC2NC(C2CCC2)=O)n1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

446.6

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.921

Distribution Coefficient, logD

3.811

Water Solubility, LogSw

-4.09

Polar Surface Area

69.649

Acid Dissociation Constant (pKa)

15.23

Base Dissociation Constant (pKb)

6.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

53.80

V025-0673 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V025-0673 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-0673?
Check Price and Availability of V025-0673, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-0673 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-0673
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-0673
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-0673 available by request